Updated Guidelines for Cerebral Venous Thrombosis

In an updated guideline, several new recommendations are provided for diagnosis and treatment of CVT.

Sponsoring Organization: American Heart Association (AHA)

Background and Objective

Cerebral venous thrombosis (CVT) is less common than arterial stroke but is an important cause of morbidity and mortality. Since the last relevant AHA statement in 2011, several new studies have been completed.

Key Points

The most commonly affected structures in CVT are the superior sagittal sinus and transverse sinus.
Clinical presentation is varied; headache is present in at least 90% of patients, seizures in 20% to 40%, and focal neurologic deficits in 20% to 50%.
Many individuals with CVT have a genetic or acquired thrombophilia (or both). New conditions identified since the last report include obesity, COVID-19, and vaccine-induced thrombocytopenia.
Magnetic re…

Reviewing Author

Seemant Chaturvedi, MD

Disclosures

Consultant/Advisory BoardBayer Pharmaceuticals; Novartis

Grant/Research SupportNational Institute of Neurological Disorders and Stroke

Editorial BoardsNeurology; Stroke